Ausgabe Sonderheft 2/2002
Current perspectives on the treatment of rheumatic diseases with infliximab
Inhalt (7 Artikel)
The determination and measurement of functional disability in rheumatoid arthritis
Frederick Wolfe
Structural damage in rheumatoid arthritis as visualized through radiographs
Désirée van der Heijde
Autoantibodies in rheumatoid arthritis and their clinical significance
Günter Steiner, Josef Smolen
Emerging role of anti-tumor necrosis factor therapy in rheumatic diseases
Joachim R Kalden